UD-GenoMed
Business Services · Hungary · 11-50 Employees
View Company Info for Free
Overview
Headquarters
HungaryPhone Number
+36 52314372Website
www.ud-genomed.huRevenue
<$5 MillionIndustry
ZI Rank: 1
About UD-GenoMed
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is UD-GenoMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if UD-GenoMed is spiking on competitors!
Check if UD-GenoMed has recently received funding, and reach out quickly before it becomes old news!
Click to see if UD-GenoMed had a recent Job posting/layoffs
Funding: Get notified immidiatlly once UD-GenoMed has new funding data
Congratulate Masked Content for being promoted to Masked Content at UD-GenoMed
Earning: See what the market has to say on UD-GenoMed recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when UD-GenoMed launches new products
UD-GenoMed, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at UD-GenoMed
Find 2 more new buyers
Company Profile Activity
Activity Insights
UD-GenoMed is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
UD-GenoMed is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about UD-GenoMed.
UD-GenoMed Tech Stack
A closer look at the technologies used by UD-GenoMed
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UD-GenoMed
The company was founded by the University of Debrecen with the ultimate goal of commercializing its genomic technology headquarter and additional services which previously were provided exclusively by the Clinical Genomic Center of UD. In 2010 the company's capital was increased by the managing individuals who acquired 50 percent of the company. UD... Read More
